Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Silvia Regazzoni"'
Autor:
Dario Gregori, Giorgia Mandrile, Giorgio V. Scagliotti, Silvia Regazzoni, Mario DeMarchi, P. Ghio, Silvia Novello, Daniela Giachino, Giovanni Selvaggi
Publikováno v:
Clinical Cancer Research. 13:2876-2881
Purpose: XRCC1 and XPD play key roles in the repair of DNA lesions and adducts. Contrasting findings have been reported on the effect of polymorphisms of these genes on the response to platinum-based chemotherapy in advanced non–small-cell lung can
Autor:
Silvia Regazzoni, A. Sambataro, Raffaello Sostegni, Marco Bardessono, Dario Gregori, Ezio Gaia, P. Salacone, Marco Astegiano, Marjan Maria van Duist, M. De Marchi, Angelo Pera, N. Sapone, Nadia Scaglione, Daniela Giachino, Francesca Bresso
CARD15 on chromosome 16 is the only IBD susceptibility gene identified among several mapped loci. Its recurrent variants R702W, G908R and L1007fs have shown significant association with Crohn's disease (CD), but not with ulcerative colitis (UC), in d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e4904af3d045da021e24cbf4e7aaaa5
http://hdl.handle.net/2318/57757
http://hdl.handle.net/2318/57757
Autor:
Paola Porcedda, Silvia Regazzoni, Mario De Marchi, Claudia Giachino, Erica Lantelme, Stefania Mantovani, Antonietta Marchi, Valentina Turinetto
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 83(10)
Ataxia-telangiectasia (AT) is a rare recessive disease with pleiotropic involvement of the nervous and lymphoid systems. AT heterozygotes have a population frequency of about 1%, and although not manifesting any overt clinical symptoms, they have an
Autor:
G.V. Scagliotti, Silvia Regazzoni, Giovanni Selvaggi, Giorgia Mandrile, Silvia Novello, P. Ghio, Daniela Giachino, M. De Marchi
Publikováno v:
Lung Cancer. 49:S69-S70
Autor:
Umberto Ricardi, G.V. Scagliotti, Silvia Novello, Giovanni Selvaggi, Silvia Regazzoni, M. De Marchi, P. Ghio, Daniela Giachino
Publikováno v:
Journal of Clinical Oncology. 22:2500-2500
2500 Background: Cisplatin and derivatives represent the cornerstone drugs in lung cancer treatment. Nevertheless, treatment related toxicities are sometime relevant and survival is still limited. Platinum-based compounds act by forming DNA adducts a
Publikováno v:
Current Medical Research & Opinion; Jul2007, Vol. 23 Issue 7, p1657-1665, 9p